- info@myglp1store.com
- +1 (904) 942-2327
- 6953 Powers avenue suite 19 Jacksonville Fl 32217
Need Any Help?
+1 (904) 942-2327
+1 (904) 942-2327
$119.00
Survodutide is a synthetic formulation associated with GLP-1, GIP, and related receptor signaling pathways. It is prepared under controlled conditions to ensure stable composition and consistent quality.
| Component | Description |
|---|---|
| Active Compound | Survodutide (synthetic formulation for GLP-1 and GIP receptor pathways) |
| Net Content | 5 mg per vial |
| Form | Lyophilized powder |
| Excipients | None added unless otherwise specified |
| Purity Verification | Analytical confirmation via HPLC or mass spectrometry |
Survodutide has well-characterized structural properties. References in scientific literature describe studies of ligand-receptor interactions, intracellular signaling activation, and metabolic pathway modulation in controlled experimental settings. All references are provided strictly for informational purposes and do not constitute clinical dosing or therapeutic guidance.
This product is intended for research purposes only. It is designated strictly for in vitro testing and laboratory experimentation and is not approved for human or animal consumption. All information provided on this website is for educational and informational purposes only. This product should be handled only by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
Survodutide 5 mg is a synthetic formulation with a well-characterized molecular structure associated with GLP-1, GIP, and related receptor pathways. Its structure enables controlled evaluation of receptor interactions, intracellular signaling, and downstream metabolic pathway responses.
Survodutide may be applied in experimental studies such as:
Receptor binding kinetics for GLP-1, GIP, and related pathways
Intracellular signaling cascade analysis
Secondary messenger and gene expression response evaluation
Comparative structureāactivity relationship analysis
Stability, degradation, and formulation studies
These studies provide mechanistic insights into multi-receptor molecular function in controlled experimental settings.
Store under recommended cold conditions to maintain stability. Handle using standard laboratory protocols. Preparation, aliquoting, and storage should follow institutional guidelines.
This formulation is provided for experimental and informational purposes only. No physiological, medical, or performance outcomes are implied or guaranteed. Users are responsible for institutional and regulatory compliance when handling this compound.
Survodutide is a synthetic formulation associated with GLP-1, GIP, and related receptor signaling pathways. It is prepared under controlled conditions to ensure stable composition and consistent quality.
| Component | Description |
|---|---|
| Active Compound | Survodutide (synthetic formulation for GLP-1 and GIP receptor pathways) |
| Net Content | 5 mg per vial |
| Form | Lyophilized powder |
| Excipients | None added unless otherwise specified |
| Purity Verification | Analytical confirmation via HPLC or mass spectrometry |
Survodutide has well-characterized structural properties. References in scientific literature describe studies of ligand-receptor interactions, intracellular signaling activation, and metabolic pathway modulation in controlled experimental settings. All references are provided strictly for informational purposes and do not constitute clinical dosing or therapeutic guidance.
Reviews
There are no reviews yet.